Found 130 matching trials
SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC NA This is a Prospective, Multicenter, Randomized Controlled study to evaluate...
Show More Location
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430030, Hubei, P. R. China
Learn More & Join Trial
Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis PHASE2 Leptomeningeal metastasis (LM) is a devastating and terminal complication o...
Show More Location
Multiple Locations
Learn More & Join Trial
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib PHASE1 The purpose of this randomized study is to determine the safety and efficac...
Show More Location
Valkyrie Clinical Trials
Learn More & Join Trial
Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer PHASE3 Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations PHASE2 This study will assess the safety and efficacy of Osimertinib with Amivanta...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification PHASE2 Osimertinib combined with savolitinib in the treatment of EGFR mutated osim...
Show More Location
Qingdao Central Hospital
Learn More & Join Trial
Phase II Study of AZD9291 in Advanced Stage NSCLC With EGFR and T790M Mutations Detected in Plasma Ct-DNA PHASE2 Circulating tumor DNA (ctDNA) is a highly specific and effective biomarker ...
Show More Location
Pamela Youde Nethersole Eastern Hospital
Learn More & Join Trial
TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases PHASE2 This study is to evaluate the efficacy and safety of TY-9591 in first-line ...
Show More Location
National Cancer Center/Cancer Hospitial,Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease PHASE1 This trial is testing two novel combinations (temozolomide plus osimertinib...
Show More Location
University of Colorado Hospital
Learn More & Join Trial
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment PHASE3 Clinical study to investigate the efficacy and safety of savolitinib in com...
Show More Status
Active Not Recruiting
Learn More & Join Trial